KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Assets (2018 - 2025)

Historic Return on Assets for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.5%.

  • Bionano Genomics' Return on Assets rose 7600.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.77% for FY2024, which is 1200.0% up from last year.
  • As of Q3 2025, Bionano Genomics' Return on Assets stood at 0.5%, which was up 7600.0% from 0.96% recorded in Q2 2025.
  • Bionano Genomics' Return on Assets' 5-year high stood at 0.14% during Q2 2021, with a 5-year trough of 1.42% in Q2 2024.
  • Its 5-year average for Return on Assets is 0.68%, with a median of 0.5% in 2025.
  • Per our database at Business Quant, Bionano Genomics' Return on Assets skyrocketed by 12800bps in 2021 and then plummeted by -9000bps in 2024.
  • Over the past 5 years, Bionano Genomics' Return on Assets (Quarter) stood at 0.2% in 2021, then tumbled by -114bps to 0.42% in 2022, then crashed by -179bps to 1.17% in 2023, then decreased by -16bps to 1.37% in 2024, then surged by 64bps to 0.5% in 2025.
  • Its Return on Assets stands at 0.5% for Q3 2025, versus 0.96% for Q2 2025 and 1.08% for Q1 2025.